Editor

8394 POSTS
0 COMMENTS

Dedication to Sufferers Is Pushed by a Lasting Promise

From left: CHRISTIE GRIFFIN-JONES, MBA-HCM, B.S.N., RN, CPHQ, CRRN, and MIKELA PETTIGREW, B.S.N., RN, OCNMikela Pettigrew, B.S.N., RN, OCN, a medical nurse at...

Understanding the FDA Imfinzi Combo Approval for Bladder Most cancers Care

Adjuvant therapy with Imfinzi (durvalumab) plus chemotherapy, adopted by single-agent, adjuvant Imfinzi following radical cystectomy obtained U.S. Meals and Drug Administration (FDA) approval...

New Choices for ER+ Breast Most cancers Spotlighted at Affected person Occasion

Dr. Brian Czerniecki, of Moffitt Most cancers Heart, led a CURE Educated Affected person® Updates in Metastatic Breast Most cancers occasion, and offered...

Evorpacept With Keytruda Did Not Elicit Responses in Head and Neck Most cancers

Evorpacept and Keytruda didn’t meet the first endpoints of the ASPEN-03 and ASPEN trials, in superior head and neck squamous cell carcinoma.Amongst sufferers...

A Digital Detox for the Soul with Lynch Syndrome

Georgia Hurst is a fierce affected person advocate for these with Lynch syndrome. Make amends for all of Georgia's blogs right here!Spring has at all...

Editor

8394 POSTS
0 COMMENTS
spot_img